|Director of the Specialty|
|Pharmaceuticals Research team|
|Oppenheimer & Co. Inc., New York City|
About John Newman
Since 2008, accomplished chemist John Newman has brought his extensive experience to Oppenheimer & Co. Inc. Currently serving as the Director of the Specialty Pharmaceuticals Research team, John Newman is instrumental in leading the team’s research endeavors for a broad range of clientele. To date, John Newman maintains coverage for over 23 companies. John Newman publishes research reports and oversees marketing with a multitude of corporate clients.
Committed to upholding the standards of his profession, John Newman manages memberships in the American Chemical Society, as well as the New York Society of Security Analysts.
John Newman first joined Oppenheimer& Co. Inc. as a Senior Specialty Pharmaceuticals Analyst. A results-driven leader, John Newman impressed colleagues with launching coverage for 12 companies within only six months of employment.
Prior to starting with Oppenheimer & Co. Inc., John Newman held a role as an Associate Analyst with Merrill Lynch. A member of the biotechnology research team, John Newman maintained models, created company reports, and liaised with clients regarding company coverage.
John Newman matriculated at the University of Maryland, Baltimore County (UMBC), from which he obtained his Ph.D. in Chemistry and Biochemistry. As a Ph.D. student, John Newman consistently demonstrated his skillful command of his chosen studies through the publication of three scientific papers over the course of his Ph.D. program. Before enrolling at UMBC, John Newman earned his Bachelor of Science in Chemistry from Loyola University Chicago. John Newman also studied biochemistry and business at the University of Wisconsin-Madison.
Beyond his professional pursuits, John Newman enjoys a variety of activities, including swimming, running, and going to the opera. John Newman enjoys spending time with his family, friends, and black Labrador retriever.
John Newman currently resides in New York City.